Pulsed Electric Field Ablation for Metastatic Breast Cancer
NCT: NCT07487844 · NOT_YET_RECRUITING
NCT IDNCT07487844
StatusNOT_YET_RECRUITING
Start Date2026-08-15
Completion2028-08-01
SponsorUniversity of California, San Francisco (OTHER)
First posted
Last updated
Brief Summary
This is a phase I trial of the safety of image-guided pulsed electric field (PEF) ablation for the locoregional treatment of superficial soft tissue lesions in adults with metastatic breast cancer using the AliyaTM Pulsed Electric Field System.
Frequently Asked Questions
What is Pulsed Electric Field Ablation for Metastatic Breast Cancer?
Pulsed Electric Field Ablation for Metastatic Breast Cancer is a clinical trial registered under NCT07487844. Current status: NOT_YET_RECRUITING.
What is the status of NCT07487844?
The current status of NCT07487844 (Pulsed Electric Field Ablation for Metastatic Breast Cancer) is: NOT_YET_RECRUITING.
When did Pulsed Electric Field Ablation for Metastatic Breast Cancer start?
Pulsed Electric Field Ablation for Metastatic Breast Cancer started on 2026-08-15.
Related Devices
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.